31.0% chaos · simmering
science fights
1 sources
Novartis to Buy Breast Cancer Drug for as Much as $3 Billion
What happened
Novartis AG agreed to buy an experimental breast cancer drug from Synnovation Therapeutics for as much as $3 billion to bolster its oncology pipeline.
Why people care
Reported by Bloomberg.
Sources
Related stories